Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA host gene 32 (SNHG32)
- Target
- SNHG32
- Molecular classification
- Long non-coding RNA (lncRNA), Small nucleolar RNA host gene (SNHG family), Non-coding RNA (ncRNA)
01
Overview
Small nucleolar RNA host gene 32 (SNHG32) is a long non-coding RNA gene involved in RNA processing and ribosome biogenesis. It is predicted to enable double-stranded RNA binding activity and is primarily located in the nucleolus. Like other SNHG family members, SNHG32 serves as a host for snoRNAs, which play crucial roles in post-transcriptional RNA modification. While the precise biological function of SNHG32 itself is not fully characterized, emerging evidence suggests that SNHG family lncRNAs participate in cancer development by modulating gene expression, cell proliferation, and apoptosis. SNHG32 may have relevance as a regulator or biomarker in certain cancers, though specific mechanisms and clinical utility remain to be clarified.
- Other names
- C6orf48D6S57G8protein G8
02
Mechanism of action
No established mechanisms for drugs exist, as it is not currently targeted by approved therapies.
03
Biological functions
RNA processingRibosome biogenesisDouble-stranded RNA binding activity (predicted)Regulation of other RNAs through hosting snoRNAsInvolvement in gene expression regulation, possibly epigenetic
04
Disease associations
Cancer (emerging evidence in gastrointestinal and breast cancer)Potential involvement as a biomarker or regulator in tumorigenesisOther: Not well-established in additional diseases
05
Safety considerations
There are no established safety concerns related to targeting SNHG32, as direct therapeutic targeting is not yet practicedTherapeutic targeting of lncRNAs generally faces challenges related to delivery, specificity, and off-target effects
06
Biomarkers
SNHG32 and other SNHG family lncRNAs are being explored as potential biomarkers, especially in cancer diagnostics and prognosis
Beyond the preview
Go deeper on Small nucleolar RNA host gene 32 (SNHG32).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Small nucleolar RNA host gene 32 (SNHG32).